Novopor Advanced Science Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.39 Cr
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 707.62 Cr
- Satisfied Charges ₹ 204.82 Cr
- Revenue Growth 56.30%
- Profit Growth -13.45%
- Ebitda 16.70%
- Net Worth 8.97%
- Total Assets 11.19%
About Novopor Advanced Science
Novopor Advanced Science Private Limited (NASPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 December 1996 and has a history of 28 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Porus Drugs And Intermediates Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.39 Cr.
The company currently has active open charges totaling ₹707.62 Cr. The company has closed loans amounting to ₹204.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novopor Advanced Science Private Limited India is Biswa Subudhi as COMPANY SECRETARY. Vipul Shah, Ajay Tyagi, Pavninder Singh, and Four other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230TG1996PTC025914
- Company No.
025914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 1996
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Novopor Advanced Science Private Limited offer?
Novopor Advanced Science Private Limited offers a wide range of products and services, including Textile, Dyeing & Finishing Chemical, Textile Chemical.
Who are the key members and board of directors at Novopor Advanced Science?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Biswa Subudhi  | Company Secretary | 11-Jan-2024 | Current |
| Radhesh Welling | Managing Director | 23-Feb-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavninder Singh | Director | Current | |
| Geeta Mathur | Director | 22-Apr-2024 | Current |
| Vipul Shah | Director | 03-Oct-2024 | Current |
| Ajay Tyagi | Director | 30-Apr-2024 | Current |
| Rishi Mandawat | Director | Current | |
| Narendra Shah | Whole-Time Director | 02-Apr-2024 | Current |
Financial Performance of Novopor Advanced Science.
Novopor Advanced Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.3% increase. The company also saw a substantial fall in profitability, with a 13.45% decrease in profit. The company's net worth moved up by a moderate rise of 8.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novopor Advanced Science?
In 2023, Novopor Advanced Science had a promoter holding of 99.82% and a public holding of 0.18%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_BRIDGE_DC_PLATFORM_PRIVATE_LIMITED.webp)
Opsmaint (India) Bridge Dc Platform Private LimitedRishi Mandawat is a mutual person
360 One Wam LimitedPavninder Singh, Rishi Mandawat and 1 more are mutual person
Deepak Nitrite LimitedVipul Shah is a mutual person
Gujarat International Finance Tec-City Company LimitedAjay Tyagi is a mutual person
Canara Hsbc Life Insurance Company LimitedGeeta Mathur is a mutual person
Rsb Transmissions (I) LtdRishi Mandawat is a mutual person
Charges (Loans)
₹707.62 Cr
₹204.82 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 367.62 Cr
- Citi Bank N.A. : 265.00 Cr
- Axis Bank Limited : 75.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2023 | Axis Bank Limited | ₹75.00 Cr | Open |
| 24 Sep 2021 | Hdfc Bank Limited | ₹75.00 Cr | Open |
| 08 Apr 2019 | Hdfc Bank Limited | ₹10.12 Cr | Open |
| 11 Jun 2018 | Citi Bank N.A. | ₹25.00 Cr | Open |
| 14 May 2018 | Citi Bank N.A. | ₹240.00 Cr | Open |
How Many Employees Work at Novopor Advanced Science?
Novopor Advanced Science has a workforce of 638 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novopor Advanced Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novopor Advanced Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
